Your browser is no longer supported

For the best possible experience using our website we recommend you upgrade to a newer version or another browser.


Your browser appears to have cookies disabled. For the best experience of this website, please enable cookies in your browser

We'll assume we have your consent to use cookies, for example so you won't need to log in each time you visit our site.
Learn more

Trial will test if blood pressure drug can slow Alzheimer's

  • Comment

A UK trial on whether the hypertension drug losartan can slow down Alzheimer’s disease will begin recruiting in August.

The multi-centre RADAR trial will be hosted by North Bristol Trust and funded with nearly £2m from the Medical Research Council. It will involve researchers from the University of Bristol, University of Cambridge and Queen’s University Belfast.

Losartan (Cazaar) is a angiotensin II receptor antagonist. Researchers believe the drug could slow down the progression of Alzheimer’s by improving brain blood flow and altering chemical pathways that cause brain cell damage, brain shrinkage and memory problems.

The Dementias and Neurodegenerative Diseases Research Network will work with participating sites to recruit 230 patients for the trial.

Funding for the study was announced by health secretary Jeremy Hunt on 20 December, as part of the prime minister’s Challenge on Dementia.

  • Comment

Have your say

You must sign in to make a comment

Please remember that the submission of any material is governed by our Terms and Conditions and by submitting material you confirm your agreement to these Terms and Conditions. Links may be included in your comments but HTML is not permitted.

Related Jobs